share_log

Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15

Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15

听说 Vistagen Therapeutics 在杰富瑞集团从持仓升级为买入;目标股价为15美元
Benzinga ·  2023/12/07 08:10

Hearing Vistagen Therapeutics Upgraded From A Hold To A Buy At Jefferies; Price Target $15

听说 Vistagen Therapeutics 在杰富瑞集团从持仓升级为买入;目标股价为15美元

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发